Saphenous Vein as Y-composite Versus Aortocoronary Conduit for CABG

Recruiting N/A Interventional Study
Coronary Artery Disease
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
19 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
290 (estimated)
Sponsor
Ho Young Hwang · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Left internal thoracic artery (LITA) has been acknowledged as the first graft of choice for coronary artery bypass grafting (CABG). However, it is still not conclusive which one is the best second graft of choice among right internal thoracic artery, radial artery, right gastroepiploic artery, saphenous vein, and etc., as well as its configuration for CABG. In our institution, saphenous vein has …
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * A patient who is going to receive coronary artery bypass grafting * Older than 19 years * Coronary artery bypass grafting is going to be performed with left internal thoracic artery and saphenous vein graft Exclusion Criteria: * Other concomitant procedures (e.g. valve or ao…
Contacts

Ho Young Hwang, MD, PhD

00-82-10-4004-3673

scalpel@snu.ac.kr

CONTACT

Suk Ho Sohn, MD

00-82-10-9114-3168

shsohn@snu.ac.kr

CONTACT